REGEnLIFE: Pioneering Light Therapy in the Fight Against Alzheimer's

Can Light Therapy Slow Alzheimer’s? The Science of Photobiomodulation with Guillaume Blivet of REGEnLIFE



On this episode of StartUp Health NOW, we learn about the power of photobiomodulation, a light therapy that promotes healing at the cellular level. From treating seasonal affective disorder to wound healing, light therapy’s applications are expanding. We’re joined by Guillaume Blivet of REGEnLIFE, a member of the StartUp Health community who is pioneering research into using photobiomodulation to address Alzheimer’s disease. Learn how their unique approach, targeting both the brain and gut, shows promise in reducing inflammation and improving cellular health. We discuss the science, the promising early results, and the potential of this groundbreaking approach.

  • Unveiling Photobiomodulation:
    • Dive into the science of photobiomodulation, a cutting-edge light therapy that stimulates cellular healing at the molecular level.
    • Explore how specific wavelengths of red and near-infrared light can trigger biological responses, reducing inflammation and promoting cellular health.
  • Beyond Traditional Light Therapy:
    • Discover how researchers are pushing the boundaries of light therapy beyond seasonal affective disorder and dermatology.
    • Learn about innovative applications of photobiomodulation for internal therapeutic benefits.
  • REGEnLIFE’s Revolutionary Approach:
    • Meet Guillaume Blivet, co-founder of REGEnLIFE, and his team’s pioneering work in applying photobiomodulation to combat Alzheimer’s disease.
    • Explore their unique strategy of targeting both the brain and the gut simultaneously, leveraging the crucial gut-brain connection.
    • Learn about the animal studies that have shown promising results.
  • Innovation in Alzheimer’s Treatment:
    • Understand how REGEnLIFE’s photobiomodulation therapy aims to slow the progression of Alzheimer’s by reducing neuroinflammation and enhancing cellular function.
    • Hear about the ongoing human trials in France and the potential for this non-invasive, safe treatment to transform Alzheimer’s care.

Tune in now as we learn how targeting the gut-brain connection with specific wavelengths of light could offer new hope for patients.


 

Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit.
» Learn more and apply today.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.